In a prospective experimental observational study of 18 individuals with severe, recurrent extracranial arteriovenous malformations, thalidomide was effective in reducing pain, healing ulceration, stopping bleeding and resolving cardiac failure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Liu, A. S., Mulliken, J. B., Zurakowski, D., Fishman, S. J. & Greene, A. K. Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast. Reconstr. Surg. 125, 1185–1194 (2010). Original publication with a large series describing the natural evolution of extracranial AVMs.
Burrows, P. E., Mulliken, J. B., Fishman, S. J., Klement, G. L. & Folkman, J. Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child. J. Craniofac. Surg. 20, 597–602 (2009). A case study demonstrating, for the first time, the efficacy of medical treatment of AVM using a metalloproteinase inhibitor.
Lebrin, F. et al. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat. Med. 16, 420–428 (2010). Original publication demonstrating efficacy of thalidomide in reducing epistaxis (nosebleed) in hereditary hemorrhagic telangiectasia.
Van Damme, A., Seront, E., Dekeuleneer, V., Boon, L. M. & Vikkula, M. New and emerging targeted therapies for vascular malformations. Am. J. Clin. Dermatol. 21, 657–668 (2020). A review article on theragnostic medical therapy for vascular anomalies based on the involved underlying molecular pathways.
Boscolo, E. et al. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J. Clin. Invest. 125, 3491–3504 (2015). Original publication demonstrating efficacy of preclinical and clinical medical treatment of slow-flow vascular anomalies with rapamycin.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Boon, L. M. et al. Case report study of thalidomide therapy in 18 patients with severe arteriovenous malformations. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-022-00080-2 (2022).
Rights and permissions
About this article
Cite this article
Efficacy of antiangiogenic medication to treat arteriovenous malformations. Nat Cardiovasc Res 1, 552–553 (2022). https://doi.org/10.1038/s44161-022-00081-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-022-00081-1
